Dilation and curettage

Clinical uses

D&Cs may be performed in pregnant and non-pregnant patients, for different clinical indications. Such examples are for early abortion, removing the remains of a non-viable pregnancy or retention of placenta from a pregnancy loss/abortion. Treatment of menopause induced anomalies with menstrual cycle.

During pregnancy or postpartum

A D&C may be performed early in pregnancy to remove pregnancy tissue, either in the case of a non-viable pregnancy, such as a missed or incomplete miscarriage, or an undesired pregnancy, as in a surgical abortion.

Dilation and curettage has been declining as a method of abortion, due to medication-based non-invasive methods of abortion, such as misoprostol and mifepristone. Suction curettage is still the most common and preferred method to ensure complete removal of remains, as the method is a completed process used for termination of a first-trimester pregnancy. The World Health Organization recommends D&C with a sharp curette as a method of surgical abortion only when manual vacuum aspiration with a suction curette is unavailable.

For patients who have recently given birth, a D&C may be indicated to remove retained placental tissue that does not pass spontaneously or for postpartum hemorrhage.

Non-pregnant patients

D&Cs for non-pregnant patients are commonly performed in tandem with Hysteroscopy another diagnostic procedure, for the diagnosis of gynecological conditions usually involving abnormal bleeding; during menopause or with various abnormal structures growing within the uterus to remove the excess uterine lining in women who have conditions such as polycystic ovary syndrome; to remove tissue in the uterus that may be causing abnormal uterine bleeding, such as endometrial polyps or uterine fibroids; or to diagnose the cause of post-menopausal bleeding, such as in the case of endometrial cancer.

Hysteroscopy is a valid alternative or addition to D&C for many surgical indications, from diagnosis of uterine pathology to the removal of fibroids and even retained tissue of Pregnancy. It allows direct visualization of the inside of the uterus and may allow targeted sampling and removal of tissue inside the uterus.

Procedure

Complications

The most common complications associated with D&C are infection, bleeding, or damage to nearby organs, including through uterine perforation. Aside from the surgery itself, complications related to anesthesia administration may also occur.

Infection is uncommon after D&C for a non-pregnant patient, and society practice guidelines do not recommend routine prophylactic antibiotics to patients. However, for curettage of a pregnant patient, the risk of infection is higher, and patients should receive antibiotics that cover the bacteria commonly found in the vagina and gastrointestinal tract; doxycycline is a common recommendation, though azithromycin may also be used.

Another risk of D&C is uterine perforation. The highest rate of uterine perforation appears to be in the setting of postpartum hemorrhage (5.1%) compared with a lower rate in diagnostic curettage in non-pregnant patients (0.3% in the premenopausal patient and 2.6% in the postmenopausal patient). Perforation may cause excessive bleeding or damage to organs outside the uterus. If the provider is concerned about ongoing bleeding or the possibility of injury to organs outside the uterus, a laparoscopy may be done to verify that there has been no undiagnosed injury.

Another potential risk is Asherman's syndrome, a condition where intrauterine adhesions lead to subfertility, amenorrhea, or recurrent pregnancy loss. Although older studies described a high (25-30%) risk of developing this condition after dilation and curettage for treatment of miscarriage, these procedures were likely done using sharp curettage, which is no longer routinely performed in modern miscarriage and abortion care. Newer studies reflect the common technique of suction curettage and demonstrate a much lower risk of Asherman's syndrome, with incidence in large prospective trials ranging from 0.7 to 1.6%. A history of multiple (3) procedures and sharp curettage were identified as risk factors for developing clinical Asherman's syndrome. A systematic review in 2013 concluded that recurrent miscarriage treated with D&C is the main risk factors for intrauterine adhesions. There are currently no studies linking asymptomatic intrauterine adhesions and long-term reproductive outcomes, and similar pregnancy outcomes have been found after miscarriage regardless of whether surgical treatment, medication management, or conservative management (i.e. watchful waiting) was chosen.

References

References

1. (November 29, 2013). "Abortion Surveillance – United States, 2010". Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, [[Centers for Disease Control]].
2. (2004-10-07). "Dilation and sharp curettage (D&C) for abortion".
3. Hayden, Merrill. (2006-02-22). "Dilation and curettage (D&C) for dysfunctional uterine bleeding".
4. Nissl, Jan. (2005-01-18). "Dilation and curettage (D&C) for bleeding during menopause".
5. (2004-10-07). "What Every Pregnant Woman Need to Know About Pregnancy Loss and Neonatal Death". WebMD.
6. (16 June 2015). "Minor surgical procedure common in O&G associated with increased risk of preterm delivery". European Society of Human Reproduction and Embryology.
7. (September 2019). "INDUCED ABORTION in The United States". [[Guttmacher Institute]].
8. (2017). "Managing Complications in Pregnancy and Childbirth: A Guide for Midwives and Do ctors". [[World Health Organization]], [[UNICEF]], United Nations Population Fund.
9. (2009). "Evacuating Retained Products of Conception in the setting of an ultrasound unit". Fertil. Steril..
10. (2000). "Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding". Eur J Gynaecol Oncol..
11. (2016). "Dilation and Curettage (D&C)". Practice Builders & Health Central Women's Care, PA.
12. "Hysteroscopy".
13. (2018-06-01). "Society of Family Planning clinical guidelines pain control in surgical abortion part 1 – local anesthesia and minimal sedation". Contraception.
14. "ACOG: FAQ: Dilation and Curettage".
15. "Dilation and curettage (D&C)". Mayo Clinic.
16. (June 2018). "ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures". American College of Obstetricians Gynecologists' Committee on Practice Bulletins – Gynecology.
17. (June 2009). "The Intraoperative Complication Rate of Nonobstetric Dilation and Curettage". Obstetrics & Gynecology.
18. (1993). "Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy – a prospective study". Hum. Reprod..
19. (1982). "Intra-uterine adhesions: an updated appraisal". Fertility and Sterility.
20. (2007). "Intrauterine adhesions and fertility outcome:how to optimize success?". Current Opinion in Obstetrics and Gynecology.
21. (2021). "Identifying the risk factors and incidence of Asherman Syndrome in women with p ost-abortion uterine curettage". Journal of Obstetrics and Gynaecology Research.
22. (2014). "Curettage and Asherman's Syndrome—Lessons to (Re-) Learn?". Journal of Obstetrics and Gynaecology Canada.
23. (2013). "Systematic review and meta-analysis of intrauterine adhesions after miscarriage: Prevalence, risk factors and long-term reproductive outcome". Human Reproduction Update.